Literature DB >> 19375616

Acute propranolol infusion stimulates protein synthesis in rabbit skin wound.

Xiao-Jun Zhang1, Chengyue Meng, David L Chinkes, Celeste C Finnerty, Asle Aarsland, Marc G Jeschke, David N Herndon.   

Abstract

BACKGROUND: Propranolol administration has been demonstrated to improve cardiac work, decrease energy expenditure, and attenuate lipolysis in burned patients; however, its effect on wound healing has not been reported.
METHODS: In rabbits, a partial-thickness skin donor site wound was created on the back, and catheters were placed in the carotid artery and jugular vein. A nasogastric feeding tube was placed for enteral feeding. On day 5 after injury, stable isotope tracers were infused to determine protein and DNA kinetics in the wound. Propranolol hydrochloride was injected in 1 group during the tracer infusion to decrease heart rate, and the other group without propranolol injection served as a control.
RESULTS: The propranolol infusion decreased heart rate by 21%. The protein fractional synthetic rate in the wound was greater in the propranolol group (8.6 +/- 0.9 vs 6.1 +/- 0.5%/day, P < .05). Wound protein fractional breakdown rates were not significantly different. The rate of protein deposition (synthesis - breakdown) was increased in the propranolol group (5.0 +/- 1.2 vs 2.8 +/- 0.7%/day, P = .07). Wound DNA fractional synthetic rates were comparable. The protein fractional synthetic rate was correlated with percent decrease in heart rate, but expression of the beta-adrenergic receptors and downstream signaling cascades in local wounds were not affected after propranolol treatment.
CONCLUSION: Propranolol infusion increased wound protein synthetic rate and tended to increase wound protein deposition rate, which might be beneficial to wound healing. These changes might reflect a systemic response to the beta-adrenergic blockade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375616     DOI: 10.1016/j.surg.2009.01.006

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing.

Authors:  Mohan R Dasu; Sandra R Ramirez; Thi Dinh La; Farzam Gorouhi; Chuong Nguyen; Benjamin R Lin; Chelcy Mashburn; Heather Stewart; Thomas R Peavy; Jan A Nolta; Roslyn R Isseroff
Journal:  Stem Cells Transl Med       Date:  2014-04-23       Impact factor: 6.940

2.  Adrenergic signaling in human oral keratinocytes and wound repair.

Authors:  P Steenhuis; R E Huntley; Z Gurenko; L Yin; B A Dale; N Fazel; R R Isseroff
Journal:  J Dent Res       Date:  2010-12-02       Impact factor: 6.116

3.  The P50 Research Center in Perioperative Sciences: How the investment by the National Institute of General Medical Sciences in team science has reduced postburn mortality.

Authors:  Celeste C Finnerty; Karel D Capek; Charles Voigt; Gabriel Hundeshagen; Janos Cambiaso-Daniel; Craig Porter; Linda E Sousse; Amina El Ayadi; Ramon Zapata-Sirvent; Ashley N Guillory; Oscar E Suman; David N Herndon
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

Review 4.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

5.  Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr
Journal:  Surgery       Date:  2015-07-21       Impact factor: 3.982

6.  β2AR antagonists and β2AR gene deletion both promote skin wound repair processes.

Authors:  Christine E Pullar; Gabrielle S Le Provost; Andrew P O'Leary; Sian E Evans; Brian S Baier; R Rivkah Isseroff
Journal:  J Invest Dermatol       Date:  2012-04-12       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.